MIM
TLSI icon

MetLife Investment Management’s TriSalus Life Sciences TLSI Stock Holding History

MetLife Investment Management’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$138K Buy
+30,413
New +$121K ﹤0.01% 2612
2026
Q1 		– Sell
-18,135
Closed -$127K – 2841
2025
Q4 		$127K Buy
+18,135
New +$102K ﹤0.01% 2490

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

MetLife Investment Management's TLSI Position: Q2 2026 in Review

MetLife Investment Management opened a new position in TriSalus Life Sciences (TLSI) in Q2 2026: 30,413 shares worth $138K. The stake represents ﹤0.01% of the portfolio and ranks #2612 among its holdings. This is a return to the name: MetLife Investment Management previously reported a position in TLSI as recently as Q4 2025.

MetLife Investment Management first reported a position in TLSI in Q4 2025 and has held it in 2 quarters since. 78 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

  • MetLife Investment Management held 30,413 shares of TriSalus Life Sciences worth $138K as of Q2 2026.
  • TriSalus Life Sciences was a new MetLife Investment Management position in Q2 2026.
  • TriSalus Life Sciences made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2612 holding.
  • MetLife Investment Management first reported a position in TriSalus Life Sciences in Q4 2025 and has held it in 2 quarters since.
  • 78 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.